These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18465228)

  • 21. Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
    Morken G; Grawe RW; Widen JH
    J Clin Psychiatry; 2007 Apr; 68(4):566-71. PubMed ID: 17474812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.
    Valenstein M; Blow FC; Copeland LA; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
    Schizophr Bull; 2004; 30(2):255-64. PubMed ID: 15279044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia.
    Byerly M; Fisher R; Whatley K; Holland R; Varghese F; Carmody T; Magouirk B; Rush AJ
    Psychiatry Res; 2005 Feb; 133(2-3):129-33. PubMed ID: 15740989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.
    Leucht C; Heres S; Kane JM; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2011 Apr; 127(1-3):83-92. PubMed ID: 21257294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mediating effect of family function and medication adherence between symptoms and mental disability among Chinese patients with schizophrenia: a cross-sectional study.
    Sun Y; Wang M; Zhou Y; Wang L; Zhang H; Lv Y; Li G
    Psychol Health Med; 2019 Jun; 24(5):559-569. PubMed ID: 30332286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adherence to antipsychotic medication in schizophrenia patients].
    Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
    Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study.
    Brnabic AJ; Kelin K; Ascher-Svanum H; Montgomery W; Kadziola Z; Karagianis J
    Int J Clin Pract; 2011 Sep; 65(9):945-53. PubMed ID: 21849009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.
    Menzin J; Boulanger L; Friedman M; Mackell J; Lloyd JR
    Psychiatr Serv; 2003 May; 54(5):719-23. PubMed ID: 12719504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication adherence among older adults with schizophrenia.
    Leutwyler HC; Fox PJ; Wallhagen M
    J Gerontol Nurs; 2013 Feb; 39(2):26-34; quiz 35. PubMed ID: 23327119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
    Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
    J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
    Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
    Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotic medication adherence in schizophrenia.
    Byerly MJ; Nakonezny PA; Lescouflair E
    Psychiatr Clin North Am; 2007 Sep; 30(3):437-52. PubMed ID: 17720031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
    Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in adherence and treatment costs following initiation of oral or depot typical antipsychotics among previously non-adherent patients with schizophrenia.
    Hong J; Novick D; Brugnoli R; Bertsch J; Haro JM
    Hum Psychopharmacol; 2013 Sep; 28(5):438-46. PubMed ID: 23775950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.